Since then, multiple studies have confirmed the superiority of [68Ga]Ga-PSMA-11 to other conventional PET tracers, such as [11C]choline, [18F]fluorocholine, and [18F]FACBC, for imaging patients with prostate cancer [113]. This evidence concerns the gene FOLH1 and prostate cancer.